Chang‐Yi Wu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Developmental Neuroscience top 10%
Papers in
-
- Angiogenesis and VEGF in Cancer 13
- Sphingolipid Metabolism and Signaling 6
- Congenital heart defects research 6
- Developmental Biology and Gene Regulation 5
- Cell Biology 19
- Zebrafish Biomedical Research Applications 13
- Co-authors
- Chien‐Chih Chiu (33 shared papers)Huimin Wang (10 shared papers)Wen‐Der Wang (8 shared papers)Yao Fong (8 shared papers)Wen‐Tsan Chang (10 shared papers)David Eide (5 shared papers)T.-I. Lin (1 shared paper)Yun‐Hsiang Lee (1 shared paper)
- Journals
- International Journal of Molecular Sciences (10 papers)The FASEB Journal (4 papers)Oxidative Medicine and Cellular Longevity (4 papers)Cancer Cell International (4 papers)Environmental Toxicology (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Chang‐Yi Wu
83 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 271
- Developmental Neuroscience 64
- Molecular Biology 717
- Critical Care and Intensive Care Medicine 53
- Cell Biology 167
Countries citing papers authored by Chang‐Yi Wu
This map shows the geographic impact of Chang‐Yi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Yi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Yi Wu more than expected).
Fields of papers citing papers by Chang‐Yi Wu
This network shows the impact of papers produced by Chang‐Yi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Yi Wu. The network helps show where Chang‐Yi Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Yi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 107 | |
| 2 | 2014 | 99 | |
| 3 | 2011 | 97 | |
| 4 | 1995 | 92 | |
| 5 | 2016 | 60 | |
| 6 | 2021 | 59 | |
| 7 | 2005 | 51 | |
| 8 | 2018 | 46 | |
| 9 | 2014 | 44 | |
| 10 | 2016 | 43 | |
| 11 | 2014 | 42 | |
| 12 | 2009 | 41 | |
| 13 | 2005 | 40 | |
| 14 | 2014 | 37 | |
| 15 | 2020 | 34 | |
| 16 | 2018 | 32 | |
| 17 | 2017 | 32 | |
| 18 | 2018 | 31 | |
| 19 | 2009 | 30 | |
| 20 | 2017 | 29 |
About Chang‐Yi Wu
Chang‐Yi Wu is a scholar working on Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 85 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (13 papers), Zebrafish Biomedical Research Applications (13 papers), Autophagy in Disease and Therapy (9 papers), Trace Elements in Health (7 papers), Sphingolipid Metabolism and Signaling (6 papers), Congenital heart defects research (6 papers), Respiratory Support and Mechanisms (6 papers) and Developmental Biology and Gene Regulation (5 papers). The work is most often cited by research in Cancer Research (271 citations), Developmental Neuroscience (64 citations), Molecular Biology (717 citations), Critical Care and Intensive Care Medicine (53 citations) and Cell Biology (167 citations). Chang‐Yi Wu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chien‐Chih Chiu, Huimin Wang, Wen‐Der Wang, Yao Fong, Wen‐Tsan Chang, David Eide, T.-I. Lin, Yun‐Hsiang Lee, Wangta Liu and Yen‐Ni Teng. Their work appears in journals such as International Journal of Molecular Sciences, The FASEB Journal, Oxidative Medicine and Cellular Longevity, Cancer Cell International and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.